Thousands of students across the state are getting free internet thanks to Comcast. Photo courtesy of Comcast

The COVID-19 pandemic shined a spotlight on the digital divide when it came to online learning, but one tech company is hoping the bridge the gap in Texas.

Comcast's Internet Essentials program and Region 4 Education Service Center have partnered with the Texas Education Agency's Connect Texas Program to make sure Texas students have access to internet services.

"Quality internet connectivity at home is critical for academic success, and we are proud to partner with Region 4 ESC to help reduce learning gaps and provide increased opportunities for students to have in-home access to the internet," says Ralph Martinez, regional senior vice president of Comcast Houston, in a news release.

Comcast's digital equity initiative provides internet access for as low as $9.95 a month, and over the past decade it has helped connect almost 1 million low-income Texans to broadband Internet at home — most for the very first time.

Houston-based Region 4 ESC is the agency leading the initiative. The TEA Connect Texas Program has a goal of connecting up to 60,000 students in kindergarten through twelfth grade through internet access and devices

"Providing stable high-quality internet to the students of Texas at home is a critical component of any long-term solution for closing the digital divide for our state," shared Gaby Rowe, Project Lead, Operation Connectivity. "The TEA Connect Texas program is designed to empower school districts and parents to do just that."

More information online on the TEA Connect Texas Program's website.

It's not the first time the tech company has supported Houston's low-income families. Last December, Comcast set up an internet voucher program with the City of Houston, and earlier this year, the company announced 50 Houston-area community centers will have free Wi-Fi connections for three years. Earlier this year, the company also dedicated $1 million to small businesses struggling due to the pandemic that are owned by Black, Indigenous, and People of Color.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

TMC launches new biotech partnership with Republic of Korea

international collaboration

Houston's Texas Medical Center has launched its new TMC Republic of Korea BioBridge.

The new partnership brings together the TMC with the Osong Medical Innovation Foundation, or KBIOHealth. The Biobridge aims to support the commercialization of Korean biotech and life science startups in the U.S., foster clinical research, and boost collaboration in the public, private and academic sectors.

Through the partnership, TMC will also develop a Global Innovators Launch Pad to foster U.S. market entry for international health care companies. Founders will be selected to participate in the 10-week program at the TMC Innovation Factory in Houston.

“Gene and cell therapies are driving biotech innovation, opening possibilities for treating diseases once thought untreatable," William McKeon, president and CEO of the Texas Medical Center, said in a news release. "Expanding biomanufacturing capacity is essential to delivering the next wave of these therapies, and partnerships with leading innovators will strengthen our efforts in Houston and internationally.”

McKeon officially signed the TMC Korea BioBridge Memorandum of Understanding with Myoung Su Lee, chairman of KBIOHealth, in South Korea in October.

"This collaboration marks a significant milestone for Korea’s biohealth ecosystem, creating a powerful bridge between Osong and Houston," Lee added in the release. "By combining KBIOHealth’s strength in research infrastructure and Korea’s biotech talent with TMC’s global network and accelerator platform, we aim to accelerate innovation and bring transformative solutions to patients worldwide.”

This is the seventh international strategic partnership for the TMC. It launched its first BioBridge with the Health Informatics Society of Australia in 2016. It launched its TMC Japan BioBridge, focused on advancing cancer treatments, last year. It also has BioBridge partnerships with the Netherlands, Ireland, Denmark and the United Kingdom.